web analytics
Beth Freeland, B.S., pharmaceutical scientist specializing in research, GMP for Velesco Pharmaceutical Services

Beth Freeland, Senior Project/Finance Manager

Scientific Leadership


Beth Freeland, B.S.


 Beth Freeland, B.S., Pharmaceutical Scientist and Scientific Leader for Velesco Pharmaceutical Services    

Beth has 10 years of experience in the pharmaceutical industry in both research and cGMP manufacturing environments. Her experience has spanned early and late phase drug development where she has supported both oral and inhaled dosage forms, including device-based products.


She joins Velesco as an Analytical Scientist after nearly six years with Pfizer Global Research & Development. Beth previously worked in the Pharmaceutical Sciences Division in Ann Arbor, Michigan where she developed and validated analytical methods to support active pharmaceutical ingredient (API) and drug product development from pre-candidate to Phase II clinical studies. In 2007, she transferred to Sandwich, England where she provided extensive analytical support for the formulation development of a dual therapy inhalation drug product in late stage development.


Beth holds a Bachelor of Science degree in Physiology from Michigan State University and is a member of the American Chemical Society (ACS).

News and Events

Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

Read the Press Release!

Dave Barnes, Ph.D. CEO/CSO is a featured speaker for the webinar Topical Formulation: Selection of Excipients and Better Process Understanding for Success in Commercial Manufacturing. Webinar recording available now.

View Recording!

Newly Acquired DEA Analytical Laboratory License. We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.

Roundtable: M&A trends in CDMO - Molecule to Market

New Velesco Pharma clinical manufacturing facility begins operations.

Read the press release here.

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.

Read the interview here.

Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.

Read the press release here.

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!

1 new job postings! Careers

Velesco's work published

Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.

Follow Velesco

LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter FB FindUsOnFacebook 100